Home / Health / India's Cervical Cancer Fight: 10M Cases Preventable
India's Cervical Cancer Fight: 10M Cases Preventable
14 May
Summary
- India could prevent over 10 million cervical cancer cases.
- Cervical cancer claims 80,000 lives annually in India.
- Screening rates are alarmingly low, especially in rural areas.
A recent modelling study in The Lancet suggests India can avert over 10 million cervical cancer cases over the next century. This ambitious goal hinges on achieving the WHO's targets for HPV vaccination and screening. Currently, India bears a heavy cervical cancer burden, with approximately 1.2 lakh new cases and 80,000 deaths annually.
The Human Papillomavirus (HPV) vaccine was first introduced in India in 2008, but uptake has been limited due to various barriers. An HPV vaccination program launched in February of this year for adolescent girls has seen uneven participation. Screening rates are critically low, with only about 2% of eligible women undergoing regular testing. Significant disparities exist, with Tamil Nadu reporting screening rates over 10% while Assam and West Bengal lag at 0.2%.
Despite challenges, India's inclusion of the HPV vaccine in its national immunization program is a significant step. Experts also propose integrating HPV nucleic acid testing into diagnostic lists to improve screening reach and accuracy. These targeted efforts offer a crucial opportunity to reduce the preventable burden of cervical cancer, especially for vulnerable populations.
